These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 10867156)
1. A novel high throughput screening assay for HCV NS3 helicase activity. Hicham Alaoui-Ismaili M; Gervais C; Brunette S; Gouin G; Hamel M; Rando RF; Bedard J Antiviral Res; 2000 Jun; 46(3):181-93. PubMed ID: 10867156 [TBL] [Abstract][Full Text] [Related]
2. DNA helicase activity of the hepatitis C virus nonstructural protein 3. Gwack Y; Kim DW; Han JH; Choe J Eur J Biochem; 1997 Nov; 250(1):47-54. PubMed ID: 9431989 [TBL] [Abstract][Full Text] [Related]
3. N-Naphthoyl-substituted indole thio-barbituric acid analogs inhibit the helicase activity of the hepatitis C virus NS3. Marecki JC; Aarattuthodiyil S; Byrd AK; Penthala NR; Crooks PA; Raney KD Bioorg Med Chem Lett; 2019 Feb; 29(3):430-434. PubMed ID: 30578035 [TBL] [Abstract][Full Text] [Related]
4. Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 protein. Wardell AD; Errington W; Ciaramella G; Merson J; McGarvey MJ J Gen Virol; 1999 Mar; 80 ( Pt 3)():701-709. PubMed ID: 10092010 [TBL] [Abstract][Full Text] [Related]
5. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). Tai CL; Chi WK; Chen DS; Hwang LH J Virol; 1996 Dec; 70(12):8477-84. PubMed ID: 8970970 [TBL] [Abstract][Full Text] [Related]
6. Fuel specificity of the hepatitis C virus NS3 helicase. Belon CA; Frick DN J Mol Biol; 2009 May; 388(4):851-64. PubMed ID: 19332076 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus NS3 NTPase/helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step. Locatelli GA; Gosselin G; Spadari S; Maga G J Mol Biol; 2001 Nov; 313(4):683-94. PubMed ID: 11697897 [TBL] [Abstract][Full Text] [Related]
8. Comparative characterization of two DEAD-box RNA helicases in superfamily II: human translation-initiation factor 4A and hepatitis C virus non-structural protein 3 (NS3) helicase. Du MX; Johnson RB; Sun XL; Staschke KA; Colacino J; Wang QM Biochem J; 2002 Apr; 363(Pt 1):147-55. PubMed ID: 11903057 [TBL] [Abstract][Full Text] [Related]
9. Physical methods to determine the binding mode of putative ligands for hepatitis C virus NS3 helicase. Sarver RW; Rogers JM; Stockman BJ; Epps DE; DeZwaan J; Harris MS; Baldwin ET Anal Biochem; 2002 Oct; 309(2):186-95. PubMed ID: 12413450 [TBL] [Abstract][Full Text] [Related]
10. Development and application of a fast, reproducible assay to measure HCV NS3 protease activity using Escherichia coli lysate. Han B; Dvory-Sobol H; Greenstein A; McCarville JF; Hung M; Liu X; Miller MD; Mo H J Virol Methods; 2015 Dec; 225():76-86. PubMed ID: 26391876 [TBL] [Abstract][Full Text] [Related]
11. Expression and purification of a hepatitis C virus NS3/4A complex, and characterization of its helicase activity with the Scintillation Proximity Assay system. Kyono K; Miyashiro M; Taguchi I J Biochem; 2004 Feb; 135(2):245-52. PubMed ID: 15047727 [TBL] [Abstract][Full Text] [Related]
12. Direct fluorometric measurement of hepatitis C virus helicase activity. Boguszewska-Chachulska AM; Krawczyk M; Stankiewicz A; Gozdek A; Haenni AL; Strokovskaya L FEBS Lett; 2004 Jun; 567(2-3):253-8. PubMed ID: 15178332 [TBL] [Abstract][Full Text] [Related]
14. An ELISA for RNA helicase activity: application as an assay of the NS3 helicase of hepatitis C virus. Hsu CC; Hwang LH; Huang YW; Chi WK; Chu YD; Chen DS Biochem Biophys Res Commun; 1998 Dec; 253(3):594-9. PubMed ID: 9918773 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the Enzymatic Activity of an NS3 Helicase Genotype 3a Variant Sequence Obtained from a Relapse Patient. Provazzi PJ; Mukherjee S; Hanson AM; Nogueira ML; Carneiro BM; Frick DN; Rahal P PLoS One; 2015; 10(12):e0144638. PubMed ID: 26658750 [TBL] [Abstract][Full Text] [Related]
16. Probing the relationship between RNA-stimulated ATPase and helicase activities of HCV NS3 using 2'-O-methyl RNA substrates. Hesson T; Mannarino A; Cable M Biochemistry; 2000 Mar; 39(10):2619-25. PubMed ID: 10704211 [TBL] [Abstract][Full Text] [Related]
17. High-throughput screening assay of hepatitis C virus helicase inhibitors using fluorescence-quenching phenomenon. Tani H; Akimitsu N; Fujita O; Matsuda Y; Miyata R; Tsuneda S; Igarashi M; Sekiguchi Y; Noda N Biochem Biophys Res Commun; 2009 Feb; 379(4):1054-9. PubMed ID: 19150342 [TBL] [Abstract][Full Text] [Related]
18. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase. Liu D; Wang YS; Gesell JJ; Wyss DF J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566 [TBL] [Abstract][Full Text] [Related]
19. Optimization of the multiple enzymatic activities of the hepatitis C virus NS3 protein. Misialek S; Rajagopalan R; Stevens SK; Beigelman L; Seiwert SD; Kossen K Anal Biochem; 2009 Nov; 394(1):138-40. PubMed ID: 19591800 [TBL] [Abstract][Full Text] [Related]
20. Fluorometric assay of hepatitis C virus NS3 helicase activity. Krawczyk M; Stankiewicz-DrogoĊ A; Haenni AL; Boguszewska-Chachulska A Methods Mol Biol; 2010; 587():211-21. PubMed ID: 20225152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]